ARTICLE | Clinical News
Acuvail 0 regulatory update
July 27, 2009 7:00 AM UTC
Allergan said FDA approved an NDA for Acuvail ketorolac tromethamine ophthalmic solution to treat pain and inflammation following cataract surgery. Allergan expects to launch the ophthalmic formulatio...